Page last updated: 2024-10-30

losartan and Epithelial Neoplasms

losartan has been researched along with Epithelial Neoplasms in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research Excerpts

ExcerptRelevanceReference
"AGTR1 protein was detected in 86% of ovarian cancer tissues, while AGTR2 was not detected in immunohistochemistry."1.40Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma. ( Bae, DS; Cho, YJ; Choi, CH; Choi, JJ; Do, IG; Jeon, HK; Kim, BG; Kim, TJ; Lee, JK; Lee, JW; Lee, YY; Park, YA; Ryu, JY; Song, SY, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Park, YA1
Choi, CH1
Do, IG1
Song, SY1
Lee, JK1
Cho, YJ1
Choi, JJ1
Jeon, HK1
Ryu, JY1
Lee, YY1
Kim, TJ1
Bae, DS1
Lee, JW1
Kim, BG1

Other Studies

1 other study available for losartan and Epithelial Neoplasms

ArticleYear
Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma.
    Gynecologic oncology, 2014, Volume: 135, Issue:1

    Topics: Angiotensin II Type 1 Receptor Blockers; Carcinoma, Ovarian Epithelial; Cells, Cultured; Disease Pro

2014